[New advances in screening and treatment of ovarian cancer].
Advances were recently observed in the early diagnosis and treatment of epithelial ovarian cancer. Molecular biology, particularly proteomics, seems to offer interesting results concerning the screening of ovarian cancer. The treatment of this tumor is based on surgery and adjuvant chemotherapy. Several studies were recently published concerning the interest and results of para-aortic lymphadenectomy and interval debulking surgery (after neo-adjuvant chemotherapy) in the surgical management of ovarian cancer. Advances in chemotherapy and new drugs will be also studied in this paper.
Morice
Philippe
P
Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif. morice@igr.fr
Pautier
Patricia
P
Bidart
Jean-Michel
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D035843:Biomedical Research; D017024:Chemotherapy, Adjuvant; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008403:Mass Screening; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D040901:Proteomics
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor